RALTITREXED for Rectal adenocarcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where RALTITREXED was used for Rectal adenocarcinoma.
Most Reported Side Effects for RALTITREXED
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 82 | 19.2% | 22 | 27 |
| Myelosuppression | 77 | 18.0% | 0 | 48 |
| Anaemia | 49 | 11.5% | 4 | 14 |
| Neutropenia | 48 | 11.2% | 4 | 20 |
| Vomiting | 46 | 10.8% | 9 | 17 |
| Nausea | 45 | 10.5% | 9 | 13 |
| Disease progression | 40 | 9.4% | 12 | 11 |
| Fatigue | 38 | 8.9% | 1 | 13 |
| Asthenia | 33 | 7.7% | 4 | 12 |
| Hepatic function abnormal | 26 | 6.1% | 1 | 8 |
| Off label use | 25 | 5.8% | 1 | 6 |
| Bone marrow failure | 23 | 5.4% | 0 | 8 |
| Decreased appetite | 21 | 4.9% | 0 | 5 |
| Thrombocytopenia | 21 | 4.9% | 1 | 2 |
| Rash | 20 | 4.7% | 0 | 9 |
Other Indications for RALTITREXED
Colon cancer (63)
Colorectal cancer metastatic (47)
Adenocarcinoma of colon (35)
Rectal cancer (31)
Colorectal cancer (28)
Metastases to liver (17)
Hepatic cancer (14)
Adenocarcinoma gastric (13)
Chemotherapy (13)
Metastatic gastric cancer (12)
Other Drugs Used for Rectal adenocarcinoma
OXALIPLATIN (1,255)
FLUOROURACIL (1,015)
CAPECITABINE (655)
IRINOTECAN (568)
BEVACIZUMAB (447)
LEUCOVORIN (337)
PANITUMUMAB (195)
CETUXIMAB (157)
LEUCOVORIN\LEUCOVORIN (101)
LEVOLEUCOVORIN (79)